Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1954 1
1962 1
1983 1
1988 2
1989 1
1990 1
1993 1
1995 1
1998 1
1999 1
2000 1
2001 1
2002 1
2003 1
2005 2
2006 1
2007 2
2009 1
2010 1
2011 2
2015 3
2016 1
2017 2
2020 1
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators. Ridker PM, et al. N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304242 Free article. Clinical Trial.
Three two-component transporters with channel-like properties have monovalent cation/proton antiport activity.
Fujisawa M, Ito M, Krulwich TA. Fujisawa M, et al. Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13289-94. doi: 10.1073/pnas.0703709104. Epub 2007 Aug 6. Proc Natl Acad Sci U S A. 2007. PMID: 17679694 Free PMC article.
Properties of four two-component bacterial transport systems of the cation/proton antiporter-2 (CPA2) family led to suggestions that this CPA2 subset may use a channel rather than an antiport mechanism [see Booth IR, Edwards MD, Gunasekera B, Li C, Miller S (2005) in Bacterial Io …
Properties of four two-component bacterial transport systems of the cation/proton antiporter-2 (CPA2) family led to suggestions that this CP …
The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study).
Ostrowska A, Wojciechowska W, Rajzer M, Weber T, Bursztyn M, Persu A, Stergiou G, Kiełbasa G, Chrostowska M, Doumas M, Parati G, Bilo G, Grassi G, Mancia G, Januszewicz A, Kreutz R; ESH ABPM COVID-19 Study Investigators. Ostrowska A, et al. Eur J Intern Med. 2025 Jan;131:58-64. doi: 10.1016/j.ejim.2024.08.027. Epub 2024 Sep 10. Eur J Intern Med. 2025. PMID: 39261181 Free article.
The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study).
Wojciechowska W, Rajzer M, Kreutz R, Weber T, Bursztyn M, Persu A, Stergiou G, Parati G, Bilo G, Pac A, Grassi G, Mancia G, Januszewicz A, Chrostowska M, Narkiewicz K, Dubiela A, Doumas M, Imprialos K, Stavropoulos K, de Freminville JB, Azizi M, Cunha PG, Lewandowski J, Strzelczyk J, Wuerzner G, Gosk-Przybyłek M, Szwench-Pietrasz E, Prejbisz A, Van der Niepen P, Kahan T, Jekell A, Spaak J, Tsioufis K, Ehret G, Doroszko A, Kubalski P, Polonia J, Styczkiewicz K, Styczkiewicz M, Mazur S, Veglio F, Rabbia F, Eula E, Águila FJ, Sarzani R, Spannella F, Jarai Z, Papadopoulos D, Lopez-Sublet M, Ostrowska A, Grassos C, Kahrimanidis I, Eugenia G, Areti T, Tomasz G, Barbara W, Aleksandra S, Beata M, Angeliki N, Robles NR, Widmiski J, Zbroch E; ESH ABPM COVID-19 Study Investigators (Excellence Centres of the European Society of Hypertension). Wojciechowska W, et al. J Hypertens. 2024 Dec 1;42(12):2065-2074. doi: 10.1097/HJH.0000000000003752. Epub 2024 Sep 19. J Hypertens. 2024. PMID: 39248094
[Bacterial ion canals].
Kubalski A, Koprowski P. Kubalski A, et al. Postepy Hig Med Dosw. 2000;54(3):317-27. Postepy Hig Med Dosw. 2000. PMID: 10941266 Review. Polish.
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.
Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G; ROADMAP Trial Investigators. Haller H, et al. N Engl J Med. 2011 Mar 10;364(10):907-17. doi: 10.1056/NEJMoa1007994. N Engl J Med. 2011. PMID: 21388309 Free article. Clinical Trial.
33 results